16/38
2.1 / 5 stars
All 38 Win/Lose results and 82 gray no-data contests shown below
SGHT Roast Me summary
Sight Sciences, Inc. (SGHT). Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth No data.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth No data.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth No data.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth No data.
Trailing 1 year (4 quarters): 2 wins, 6 losses, 4 no dataLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/2 |
WinSGHT / S&P 43.77% / 15.20% |
LoseSGHT / S&P 9.27% / 15.00% |
No dataSGHT / S&P / 50.40% |
| 2026-Q10/2 |
LoseSGHT / S&P -52.46% / -4.33% |
LoseSGHT / S&P 1.85% / 11.30% |
No dataSGHT / S&P / 27.70% |
| 2025-Q41/2 |
WinSGHT / S&P 130.52% / 2.65% |
LoseSGHT / S&P -3.13% / 9.00% |
No dataSGHT / S&P / 13.40% |
| 2025-Q30/2 |
LoseSGHT / S&P -16.71% / 8.12% |
LoseSGHT / S&P -4.39% / 4.61% |
No dataSGHT / S&P / 13.45% |
| 2025-Q21/2 |
WinSGHT / S&P 72.08% / 10.94% |
LoseSGHT / S&P -3.89% / 4.83% |
No dataSGHT / S&P / 10.63% |
| 2025-Q10/2 |
LoseSGHT / S&P -34.07% / -4.27% |
LoseSGHT / S&P -4.16% / 4.98% |
No dataSGHT / S&P / 10.57% |
| 2024-Q40/2 |
LoseSGHT / S&P -42.22% / 2.41% |
LoseSGHT / S&P -1.47% / 5.25% |
No dataSGHT / S&P / 6.15% |
| 2024-Q30/2 |
LoseSGHT / S&P -5.55% / 5.89% |
LoseSGHT / S&P -3.99% / 5.89% |
No dataSGHT / S&P / 6.11% |
| 2024-Q21/2 |
WinSGHT / S&P 26.33% / 4.28% |
LoseSGHT / S&P -2.60% / 5.38% |
No dataSGHT / S&P / 5.12% |
| 2024-Q11/2 |
LoseSGHT / S&P 2.33% / 10.56% |
WinSGHT / S&P 8.27% / 5.71% |
No dataSGHT / S&P / 5.59% |
| 2023-Q42/2 |
WinSGHT / S&P 53.12% / 11.69% |
WinSGHT / S&P 13.63% / 6.81% |
No dataSGHT / S&P / 7.78% |
| 2023-Q31/2 |
LoseSGHT / S&P -59.30% / -3.27% |
WinSGHT / S&P 26.54% / 7.52% |
No dataSGHT / S&P / -5.03% |
| 2023-Q21/2 |
LoseSGHT / S&P -5.26% / 8.74% |
WinSGHT / S&P 36.09% / 9.50% |
No dataSGHT / S&P / -8.57% |
| 2023-Q11/2 |
LoseSGHT / S&P -28.42% / 7.50% |
WinSGHT / S&P 36.36% / 10.77% |
No dataSGHT / S&P / -15.69% |
| 2022-Q42/2 |
WinSGHT / S&P 92.28% / 7.56% |
WinSGHT / S&P 45.70% / 11.88% |
No dataSGHT / S&P / -17.99% |
| 2022-Q31/2 |
LoseSGHT / S&P -29.37% / -4.88% |
WinSGHT / S&P 51.34% / 13.47% |
No dataSGHT / S&P / -1.41% |
| 2022-Q21/2 |
LoseSGHT / S&P -22.23% / -16.10% |
WinSGHT / S&P 54.32% / 13.71% |
No dataSGHT / S&P / 11.04% |
| 2022-Q11/2 |
LoseSGHT / S&P -34.21% / -4.60% |
WinSGHT / S&P 85.37% / 15.97% |
No dataSGHT / S&P / 42.23% |
| 2021-Q41/2 |
LoseSGHT / S&P -22.60% / 11.03% |
WinSGHT / S&P 77.12% / 15.00% |
No dataSGHT / S&P / 96.40% |
| 2021-Q30/0 |
No dataSGHT / S&P / 0.58% |
No dataSGHT / S&P / 10.77% |
No dataSGHT / S&P / 69.42% |
| 2021-Q20/0 |
No dataSGHT / S&P / 8.55% |
No dataSGHT / S&P / 6.58% |
No dataSGHT / S&P / 51.81% |
| 2021-Q10/0 |
No dataSGHT / S&P / 6.17% |
No dataSGHT / S&P / -1.06% |
No dataSGHT / S&P / 7.39% |
| 2020-Q40/0 |
No dataSGHT / S&P / 12.15% |
No dataSGHT / S&P / -3.72% |
No dataSGHT / S&P / -33.42% |
| 2020-Q30/0 |
No dataSGHT / S&P / 8.93% |
No dataSGHT / S&P / -2.04% |
No dataSGHT / S&P / -27.10% |
| 2020-Q20/0 |
No dataSGHT / S&P / 20.54% |
No dataSGHT / S&P / -0.46% |
No dataSGHT / S&P / -27.11% |
| 2020-Q10/0 |
No dataSGHT / S&P / -19.60% |
No dataSGHT / S&P / 3.47% |
No dataSGHT / S&P / -14.75% |
| 2019-Q40/0 |
No dataSGHT / S&P / 9.07% |
No dataSGHT / S&P / 5.36% |
No dataSGHT / S&P / 2.99% |
| 2019-Q30/0 |
No dataSGHT / S&P / 1.70% |
No dataSGHT / S&P / 5.02% |
No dataSGHT / S&P / 0.21% |
| 2019-Q20/0 |
No dataSGHT / S&P / 4.30% |
No dataSGHT / S&P / 6.64% |
No dataSGHT / S&P / 8.65% |
| 2019-Q10/0 |
No dataSGHT / S&P / 13.65% |
No dataSGHT / S&P / 8.12% |
No dataSGHT / S&P / 14.29% |
| 2018-Q40/0 |
No dataSGHT / S&P / -13.52% |
No dataSGHT / S&P / 9.05% |
No dataSGHT / S&P / 18.23% |
| 2018-Q30/0 |
No dataSGHT / S&P / 7.71% |
No dataSGHT / S&P / 10.21% |
No dataSGHT / S&P / 19.06% |
| 2018-Q20/0 |
No dataSGHT / S&P / 3.43% |
No dataSGHT / S&P / 9.03% |
No dataSGHT / S&P / 14.46% |
| 2018-Q10/0 |
No dataSGHT / S&P / -0.76% |
No dataSGHT / S&P / 7.68% |
No dataSGHT / S&P / 12.46% |
| 2017-Q40/0 |
No dataSGHT / S&P / 6.64% |
No dataSGHT / S&P / 7.03% |
No dataSGHT / S&P / 13.82% |
| 2017-Q30/0 |
No dataSGHT / S&P / 4.48% |
No dataSGHT / S&P / 5.68% |
No dataSGHT / S&P / 17.57% |
| 2017-Q20/0 |
No dataSGHT / S&P / 3.09% |
No dataSGHT / S&P / 4.83% |
No dataSGHT / S&P / 17.74% |
| 2017-Q10/0 |
No dataSGHT / S&P / 6.07% |
No dataSGHT / S&P / 3.67% |
No dataSGHT / S&P / 13.32% |
| 2016-Q40/0 |
No dataSGHT / S&P / 3.82% |
No dataSGHT / S&P / 2.09% |
No dataSGHT / S&P / 7.05% |
| 2016-Q30/0 |
No dataSGHT / S&P / 3.85% |
No dataSGHT / S&P / 0.20% |
No dataSGHT / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | SGHT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 110.10% | 20.78% |
| Annualized return | 110.10% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | SGHT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -70.33% | 83.14% |
| Annualized return | -21.57% | 12.86% |
10Y · 2021-07-15 to 2026-08-28
| Metric | SGHT total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -74.54% | 319.30% |
| Annualized return | -12.79% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |